XLO
Xilio Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:52:33 PM EDT
8.89USD-0.224%(-0.02)7,401
Pre-marketOct 2, 2026 8:04:30 AM EDT
8.74USD-1.908%(-0.17)
XLO News
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · 
GlobeNewswire Inc.
Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer · GlobeNewswire Inc.
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · GlobeNewswire Inc.